Scleroderma Lung Involvement | Medical Algorithm

Evaluation

Are you evaluating a patient with systemic sclerosis?

Yes

DLCO as percent of predicted (enter from 0 to 100)

FVC as percent of predicted (enter from 0 to 100)

Are bibasilar rales heard on lung auscultation?

Yes

Is there evidence of pulmonary fibrosis seen on chest X-ray?

Yes

Is supplemental oxygen required?

Yes

Presence of pulmonary hypertension

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Grade of lung involvement

Descriptor for lung involvement

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Scleroderma Risk Model for 5 Year Survival
Clinical Diagnosis, Including Family History For Genetics
- ARA Scleroderma Criteria Cooperative Study Preliminary Clinical Criteria for Systemic Sclerosis
Imaging Studies
Laboratory Tests
Other Testing
Criteria For Diagnosis
Severity, Prognosis, Stage
Differential Diagnosis And Mimics, Red Flags

Therapy

Physical And Lifestyle
- Drug Induced Scleroderma

Monitoring

Response To Therapy
Disease Progression
Comorbid Conditions
- Prognostic Factors for Patient with Juvenile Systemic Sclerosis

Patient Concerns

End-of-life, Palliative Care
- Scleroderma Risk Model for 5 Year Survival

Specialty

Immunology/Rheumatology

Objective

imaging studies
severity
prognosis
stage
disease progression
comorbid conditions

ICD-10

M34 - Systemic sclerosis

Lung Severity Scale of Medsger for Patient with Systemic Sclerosis

Purpose: To identify lung involvement in a patient with systemic sclerosis using the lung severity scale of Medsger et al.